*As of June 30 2025 Mounjaro is one of the brand names for the medication tirzepatide
Phase 2 trials have included striatal binding of dopamine transporter in the secondary outcome measures (NCT03100149, NCT03318523, Table 2), which would be of interest to correlate with the clinical outcome measures, and the biofluid-measured alterations to improve understanding of the drug action mechanism
The assessed variables were total prostate-specific antigen, prostate volume, peak systolic velocity, end-diastolic velocity, resistive index of cavernosal penile arteries, nocturnal penile tumescence, total and free testosterone, prolactin, luteinizing hormone, International Index of Erectile Function score, Depression Melancholia Scale score, fatigue scale score, and incidence of side effects
Suggested Use: 1 capsule 1-3 times daily
doi: 10.1186/s13059-014-0550-8 32 MaD.TangH.ReicheltM.PiirtolaE
The interaction between tirzepatide and blood work is an important consideration for anyone managing multiple medications simultaneously